2022 World Tobacco Development Report: Emerging Nicotine Pouch Trend

Jun.15.2023
2022 World Tobacco Development Report: Emerging Nicotine Pouch Trend
The report on the global tobacco industry in 2022 highlights the rapid growth of nicotine pouches and stable sales of traditional smokeless tobacco.

Recently, the Oriental Tobacco Report released an article titled "2022 Global Tobacco Development Report (Part I)," written by the Policy Research Office of the National Bureau of Economic Research.


The article mentions that nicotine pouches, also known as modern oral tobacco, are the fastest-growing new tobacco product in recent years. Sales are expected to reach 10.65 billion pouches in 2022, a 56.1% increase from the previous year, with a sales revenue of 5.33 billion US dollars, a 77.7% increase. However, their market share in the global tobacco product sales is still less than 1%, with the main markets concentrated in the United States and the Nordic region, such as Sweden, Norway, and Denmark.


Sales of traditional cigarettes remained stable, with a total sales volume of 121,000 tons and revenue of $13.95 billion. Hand-rolled and pipe tobacco maintained slow growth, with respective sales volumes of 104,000 tons (equivalent to 2.958 million boxes of cigarettes) and 146,000 tons, a year-on-year increase of 1.9% and 2.5%. Revenue for hand-rolled and pipe tobacco reached $34.39 billion and $7.93 billion, respectively, a year-on-year growth of 6.6% and 8.7%.


Reference materials:


World Tobacco Development Report 2022 (Part 1)


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
Special Report | New Patents Show China Tobacco Hubei Industrial Testing Gas-Releasing Nicotine Pouches
Special Report | New Patents Show China Tobacco Hubei Industrial Testing Gas-Releasing Nicotine Pouches
Newly published patent filings indicate that China Tobacco Hubei Industrial Co., Ltd., a subsidiary of China National Tobacco Corporation (CNTC), is exploring nicotine pouch technologies capable of releasing gas during oral use. The designs include carbon-dioxide microcapsules that burst in the mouth and effervescent systems that generate gas through chemical reactions with saliva, suggesting efforts to introduce new sensory dynamics into modern oral nicotine products.
News
Mar.04
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
The Irish government has approved the publication of the Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026. The bill would ban the sale of nicotine consumption products such as nicotine pouches to those under 18 and further regulate nicotine vaping products.
Mar.05 by 2FIRSTS.ai
Arizona’s Operation Counter Strike Conducts 1,882 Tobacco Retailer Inspections in Fiscal 2025, Issues 451 Criminal Citations
Arizona’s Operation Counter Strike Conducts 1,882 Tobacco Retailer Inspections in Fiscal 2025, Issues 451 Criminal Citations
Arizona Attorney General Kris Mayes announced the results of the Attorney General’s Office “Operation Counter Strike” program on March 9, 2026.
Mar.11 by 2FIRSTS.ai
Kansas Lawmakers Hear SB 355 to License E-Cigarette Makers, Citing Illicit China Imports
Kansas Lawmakers Hear SB 355 to License E-Cigarette Makers, Citing Illicit China Imports
Kansas lawmakers held a Senate committee hearing on Senate Bill 355 on Jan. 27. The proposal would require e-cigarette manufacturers—potentially affecting distributors as well—to obtain a state license, expanding oversight beyond retailers.
Jan.28 by 2FIRSTS.ai